Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Genosomes are promising for safe and effective gene delivery in therapy.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Combining low-level laser therapy and exosome therapy promotes hair growth.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Tranexamic acid and oral retinoids may effectively treat lichen plan pigmentosus.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Prostaglandins may protect hair follicles during chemotherapy.

Laser-Assisted Exosome Delivery showed early skin improvement without side effects, but more research is needed.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Ruxolitinib can cause a delayed skin reaction on the nose.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Luteolin-loaded nanoformulations could improve cancer treatment by enhancing luteolin's effectiveness.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.